Danish enzyme producer Novozymes acquires probiotic solution provider, PrecisionBiotics for US$90.3m
IRELAND – Global biotechnology company, Novozymes has acquired PrecisionBiotics Group for DKK 600 million (US$90.3m),…
Novozymes
Danish initiative P4G funds manufacturing of protein-rich biscuit in Ethiopia
ETHIOPIA – Partnering for Green Growth and Global Goals (P4G), a Danish initiative has invested…
Novozymes launches new lactase to improve nutritional profile of dairy products
DENMARK – The Danish biological solutions company, Novozymes is launching Saphera Fiber, a new lactase…
Green Plains and Novozymes partner in production of protein ingredients
USA – Diversified commodity-processing company, Green Plains has entered into an exclusive partnership with Danish…
Novozymes unveils new enzymatic toolbox for development of oat drinks
DENMARK – Novozymes has developed a new toolbox to help guide producers on expanding their…
Novozymes makes organizational changes to deliver on growth strategy
DENMARK – The biological solutions company, Novozymes has announced some organizational changes that will include…
Court rules in favor of DuPont in Danisco patent ownership case
DENMARK – The Danish Maritime and Commercial Court has confirmed DuPont’s ownership of two amylase…
Denmark based biotech company Novozymes opens regional office in Kenya
KENYA – Novozymes, a Denmark based global biotechnology company, has opened a regional office in…
Novozymes invites collaboration on global challenges
DENMARK – Novozymes, the world leader in biological solutions, has launched HelloScience, an online network…
Top court rules in favor of Novozymes in patent dispute with Chinese firms
CHINA – The Supreme People’s Court of China, the country’s highest court, has ruled against two local firms in a patent infringement case brought by enzyme maker, Novozymes, in what the company calls an ‘important step towards protecting biotech innovations.’
Top court rules in favor of Novozymes in patent dispute with Chinese firms
CHINA – The Supreme People’s Court of China, the country’s highest court, has ruled against two local firms in a patent infringement case brought by enzyme maker, Novozymes, in what the company calls an ‘important step towards protecting biotech innovations.’